Ray Co

Ray Co CapEx/D&A

The CapEx to Depreciation Ratio of Ray Co (228670.KQ) as of Nov 18, 2026 is 0.49. In the previous year, CapEx to Depreciation Ratio was 0.22 — a change of 121.22% (higher).

CapEx/D&A

0.49

YoY

121.22%

Last updated:

CapEx to Depreciation Ratio of Ray Co is 2024 0.49 . CapEx to Depreciation Ratio of Ray Co was 2023 0.22 . It decreases by 121.22% higher compared to the previous year.

The Ray Co CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2017
11.30 KRW
Jan 1, 2018
11.21 KRW
Jan 1, 2019
1.11 KRW
Jan 1, 2020
2.58 KRW
Jan 1, 2021
10.80 KRW
Jan 1, 2022
9.56 KRW
Jan 1, 2023
0.22 KRW
Jan 1, 2024
0.49 KRW
The Ray Co CapEx/D&A history
YEARCapEx/D&AYoY
0.49+121.22%
0.22-97.68%
9.56-11.46%
10.80+318.97%
2.58+132.65%
1.11-90.12%
11.21-0.80%
11.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

CapEx to Depreciation Ratio of Ray Co is 0.49 in 2024.

CapEx to Depreciation Ratio of Ray Co changed from 0.22 to 0.49, representing a 121.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Ray Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ray Co

All Key Metrics — Ray Co